Navigation Links
ARx(TM) Opens New Pharmaceutical Manufacturing Facility
Date:9/19/2007

Company Expanding to Meet the Global Demands for Innovative Drug Delivery

Systems

GLEN ROCK, Pa., Sept. 19 /PRNewswire/ -- ARx(TM), LLC, a subsidiary of Adhesives Research, is pleased to announce the official opening of its new state-of-the-art pharmaceutical manufacturing facility just eighteen months after breaking ground.

The new 25,000 square-foot facility is designed to manufacture dissolvable film, transdermal, and buccal drug delivery systems for over-the-counter (OTC), prescription, and biopharmaceutical products. The globally-compliant facility triples ARx's manufacturing capacity and laboratory space to support its rapidly growing portfolio of projects and clients.

ARx currently supports multiple commercial thin film products sold in the United States, Canada and Latin America, including Novartis Consumer Health's Triaminic(R) Thin Strips(TM) pediatric and infant cough and cold products, Theraflu(R) Thin Strips(TM) cold and flu products, and Gas-X(R) Thin Strips(TM) anti-gas relief products. The current facility and evolving pipeline further supports ARx's market leadership by quadrupling potential strip output to over 1.4 billion strips per year.

"We have used our knowledge and twenty-plus years of experience in the pharmaceutical industry to build a modern, globally-compliant facility that allows us to streamline the manufacturing process and create an efficient and flexible process for our clients," said Beth Vondrak, ARx Vice President and General Manager.

Dissolvable thin film technology gives consumers a choice of delivery options for taking OTC and prescription medicines. The key benefits of the technology include quick and precise dosing, convenience and portability. These films have proven to be very popular for the pediatric population, who usually ingest the entire thin film dose (versus liquids that can be expelled from the mouth), as well as with geriatric patients and other individuals who have difficulty swallowing pills and those who prefer on-the-go relief.

ARx, a subsidiary of Adhesives Research, was created in 2005 to address the growing global need for innovative delivery of active drug-containing systems and is a custom developer and supplier of high-quality drug and biopharmaceutical delivery materials and technologies for the pharmaceutical industry. Adhesives Research has over 20 years of experience in providing unique components for transdermal, oral and topical drug delivery. The new facility brings the total square footage at the company's corporate headquarters to more than 240,000 square feet.

For more information on ARx and Adhesives Research, please call 717-235-7979 (1-800-445-6240) or visit http://www.adhesivesresearch.com.


'/>"/>
SOURCE ARx, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. First global SARS meet opens
2. Cancer Drug Opens Arteries
3. Ranbaxy opens Drug discovery centre in Gurgaon
4. Delhi Hospital Opens Up Avenues For Computer-Aided Knee Replacement
5. Cancer Hospice Opens New In-patient Unit
6. Center for Celiac Disease Opens
7. Review Opens Bag of Tricks for Reducing Pain from Children’s Shot
8. Apollo Eyes Expansion in Kolkata, Opens Ayurveda Clinic
9. Largest Ever African HIV Vaccine Trial Opens in South Africa
10. Apollo Opens Blood Cancer Clinic in Kolkata
11. China Opens Doors For Foreign Investments In Hospitals Care System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a ... and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is ... to some of the world’s leading providers of cereal and other breakfast foods. Its ...
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... June 23, 2016 Revolutionary technology ... Oticon , industry leaders in advanced audiology and ... Oticon Opn ™, the world,s first internet connected ... for IoT devices.      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ... a number of ,world firsts,: , TwinLink™ ...
Breaking Medicine Technology: